MENU
MGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Metagenomi Therapeutics (MGX) Ownership - Who owns Metagenomi Therapeutics?

Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients... Show more

Profile

Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
119
Web
https://metagenomi.co

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
43.07M
P/E Ratio
N/A
Total Cash
120.66M
Projected Growth
N/A
Total Debt
37.72M
Revenue
13.56M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.19
Total Debt/Equity
N/A
Revenue/Share
0.36 USD as % of share price
Who owns Metagenomi Therapeutics? MGX symbol Ownership - Tickeron.com